U.S. Food and Drug Administration authorizes a booster dose of the Pfizer–BioNTech and Moderna COVID-19 vaccines for immunocompromised people
The U.S. Food and Drug Administration authorizes a booster dose of the Pfizer–BioNTech and Moderna COVID-19 vaccines for immunocompromised people.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan to read this report and the complete Premium retrospective archive.
HealthU.S. Food and Drug Administration authorizes a booster dose of the Pfizer–BioNTech and Moderna COVID-19 vaccines for immunocompromised people
View Premium plansBrowse free archive reportsThe U.S. Food and Drug Administration authorizes a booster dose of the Pfizer–BioNTech and Moderna COVID-19 vaccines for immunocompromised people.